XML 15 R6.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
¥ in Millions, $ in Millions
Total Alibaba Group Holding Limited shareholders' equity (deficits)
CNY (¥)
Ordinary Shares
CNY (¥)
shares
Additional paid-in capital
CNY (¥)
Restructuring reserve
CNY (¥)
Subscription receivables
CNY (¥)
Statutory reserves
CNY (¥)
Cumulative translation adjustments
CNY (¥)
Unrealized gains (losses) on interest rate swaps and others
CNY (¥)
Retained earnings (Accumulated deficits)
CNY (¥)
Noncontrolling interest
CNY (¥)
CNY (¥)
shares
USD ($)
shares
Balance at Mar. 31, 2019 ¥ 492,257 ¥ 1 ¥ 231,783 ¥ (97) ¥ (49) ¥ 5,068 ¥ (2,592) ¥ 257 ¥ 257,886 ¥ 116,326 ¥ 608,583  
Balance (in shares) at Mar. 31, 2019 | shares   20,696,476,576                    
Increase (Decrease) in Stockholders' Equity                        
Foreign currency translation adjustment 2,403       (2)   2,397 8   400 2,803  
Share of additional paid-in capital and other comprehensive income of equity method investees (169)   (107)       (62)       (169)  
Change in fair value of interest rate swaps under hedge accounting and others (225)             (225)     (225)  
Net income for the period 94,039               94,039 (4,010) 90,029  
Acquisition of subsidiaries 2,252   2,252             (572) 1,680  
Acquisition of subsidiaries (in shares) | shares   14,329,896                    
Issuance of shares, including vesting of RSUs and early exercised options and exercise of share options 421   421               421  
Issuance of shares, including vesting of RSUs and early exercised options and exercise of share options (in shares) | shares   154,876,656                    
Repurchase and retirement of ordinary shares (in shares) | shares   (34,120)                    
Transactions with noncontrolling interests (1,334)   (1,334)             3,605 2,271  
Amortization of compensation cost 13,305   13,305             1,954 15,259  
Appropriation to statutory reserves           513     (513)      
Others (150)   (247) ¥ 97           (271) (421)  
Balance at Sep. 30, 2019 602,799 ¥ 1 246,073   (51) 5,581 (257) 40 351,412 117,432 720,231  
Balance (in shares) at Sep. 30, 2019 | shares   20,865,649,008                    
Balance at Mar. 31, 2020 755,401 ¥ 1 343,707   (51) 6,100 (387) (256) 406,287 115,147 ¥ 870,548  
Balance (in shares) at Mar. 31, 2020 | shares   21,491,994,944                 21,491,994,944 21,491,994,944
Increase (Decrease) in Stockholders' Equity                        
Foreign currency translation adjustment (8,777)       2   (8,788) 9   (794) ¥ (9,571)  
Share of additional paid-in capital and other comprehensive income of equity method investees 865   571       293 1   1 866  
Change in fair value of interest rate swaps under hedge accounting and others 14             14     14 $ 2
Net income for the period 76,409               76,409 (3,441) 72,968  
Issuance of shares, including vesting of RSUs and early exercised options and exercise of share options 144   144               144  
Issuance of shares, including vesting of RSUs and early exercised options and exercise of share options (in shares) | shares   163,972,568                    
Repurchase and retirement of ordinary shares (in shares) | shares   (8,544)                    
Transactions with noncontrolling interests 2,960   2,960             2,491 5,451  
Amortization of compensation cost 30,436   30,436             2,577 33,013  
Appropriation to statutory reserves           776     (776)      
Others (49)   (49)             (194) (243)  
Balance at Sep. 30, 2020 ¥ 857,403 ¥ 1 ¥ 377,769   ¥ (49) ¥ 6,876 ¥ (8,882) ¥ (232) ¥ 481,920 ¥ 115,787 ¥ 973,190 $ 143,335
Balance (in shares) at Sep. 30, 2020 | shares   21,655,958,968                 21,655,958,968 21,655,958,968